Events & Presentations

Upcoming Events
More events are coming soon.
Archived Events
Date Event Details
Aug 4, 2022 4:30 PM EDT
Arrowhead Pharmaceuticals 2022 Third Quarter Results
Jun 22 - Jun 26, 2022
The International Liver Congress™ 2022 - The Annual Meeting of the European Association for the Study of the Liver (EASL)

Title: Effects of the siRNA JNJ-3989 and/or the Capsid Assembly Modulator JNJ-6379 on Viral Markers of Chronic Hepatitis B: Results From the REEF-1 Study
Presenter: Man-Fung Yuen, Department of Medicine & State Key Laboratory of Liver Research, Queen Mary Hospital, The University of Hong Kong

Title: Understanding the Dynamics of HBsAg Decline Through Model-informed Drug Development (MIDD) of siRNA and CAM-N for the Treatment of Chronic Hepatitis B (CHB) Virus Infection
Presenter: Huybrecht T’jollyn, Janssen Research & Development

Title: Efficacy and Safety of Finite 48-week Treatment With the siRNA JNJ-3989 and the Capsid Assembly Modulator JNJ-6379 in HBeAg Negative Virologically Suppressed Chronic Hepatitis B Patients: Results from the REEF-2 Study
Presenter: Kosh Agarwal, Institute of Liver Studies, King’s College Hospital

Title: Reduction of Intra-hepatic Z-AAT Synthesis by Fazirsiran Decreases Globule Burden and Improves Histological Measures of Liver Disease in Adults with Alpha-1 Antitrypsin Deficiency
Presenter: Pavel Strnad, Department of Internal Medicine III, University Hospital, Rwth Aachen

Jun 13 - Jun 16, 2022
Goldman Sachs 43rd Annual Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Jun 8, 2022 8:30 AM EDT
Jefferies Healthcare Conference
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
May 26, 2022 10:00 AM EDT
Pulmonary R&D Day
New York
May 25, 2022 12:15 PM EDT
UBS Global Healthcare Conference 2022
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
May 17, 2022 4:35 PM EDT
2022 RBC Capital Markets Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals
May 13 - May 18, 2022
2022 American Thoracic Society (ATS) International Conference
Title: Silencing RAGE Expression with a Lung-Targeted RNAi Trigger Delivery Platform Suppresses Pulmonary Allergic Inflammation
Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals
    
Title: Silencing Muc5ac Expression with a Lung-Targeted RNAi Trigger Prevents Allergen-Induced Mucoobstruction and Airway Hyperresponsiveness
Presenter: David Kasahara, Senior Scientist III, Biology, Arrowhead Pharmaceuticals
 
May 12, 2022 1:40 PM EDT
BofA Securities 2022 Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, President and CEO, Arrowhead Pharmaceuticals
 
May 10, 2022 4:30 PM EDT
Arrowhead Pharmaceuticals 2022 Second Quarter Results